- Home
- FLNA vs AEI Comparison
FLNA vs AEI Comparison
Compare FLNA & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNA | AEI |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 54.1M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FLNA | AEI |
|---|---|---|
| Price | $0.92 | $1.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 316.7K | 7.1K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,119,000.00 | $16,238,200.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.86 | $1.00 |
| 52 Week High | $2.03 | $4.55 |
Technical Indicators
Market Signals| Indicator | FLNA | AEI |
|---|---|---|
| Relative Strength Index (RSI) | 36.90 | 57.95 |
| Support Level | $0.86 | $1.20 |
| Resistance Level | $1.80 | $1.58 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 29.91 | 84.85 |
Price Performance
Historical ComparisonAbout FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: Real Estate, Digital Transformation Technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.